Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AETHLON MEDICAL INCAEMD · Entity 8580 | Director · Chairman, CEO, Secretary | October 31, 2018 | November 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AETHLON MEDICAL INC
Report date October 31, 2018 · Filed November 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 212,370 |
Reported balance
After 2018-10-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-10-31 · Exercise / conversion · Acquired 18,683 · Balance 212,370 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F1: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 279,064 |
Reported balance
After 2018-10-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-10-31 · Conversion · Disposed 39,625 · Balance 279,064 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F3: 158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 10/31/2018. |
Filing footnotes · ownership attribution and instrument terms
F1: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised.
F3: 158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 10/31/2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 31, 2018 Filed Nov 2, 2018 22:28 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | ConversionRestricted Stock Units · Derivative | 39,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-003227 · ownership.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,064 Underlying: Common Stock · 39,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 10/31/2018. F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 10/31/2018. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 22:28 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 18,683 | $1.04 | $19,430.32 |
DisclosureSEC source: 0001683168-18-003227 · ownership.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 14:33 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | ConversionRestricted Stock Units · Derivative | 39,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-002088 · ownership.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,689 Underlying: Common Stock · 39,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 7/31/2018. F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 3,250 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of 7/31/2018. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 14:33 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 18,683 | $1.23 | $22,980.09 |
DisclosureSEC source: 0001683168-18-002088 · ownership.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
| April 30, 2018 Filed May 3, 2018 01:07 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | ConversionRestricted Stock Units · Derivative | 39,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-001166 · joyce_frm4.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,314 Underlying: Common Stock · 39,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of April 30, 2018. F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of April 30, 2018. Read SEC document |
| April 30, 2018 Filed May 3, 2018 01:07 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 18,771 | $1.34 | $25,153.14 |
DisclosureSEC source: 0001683168-18-001166 · joyce_frm4.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:32 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | ConversionRestricted Stock Units · Derivative | 39,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-000294 · joyce_frm4.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,939 Underlying: Common Stock · 39,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of January 31, 2018. F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of January 31, 2018. Read SEC document |
| January 31, 2018 Filed Feb 3, 2018 01:32 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 16,979 | $1.50 | $25,468.50 |
DisclosureSEC source: 0001683168-18-000294 · joyce_frm4.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
| December 29, 2017 Filed Jan 4, 2018 20:40 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | GiftCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-18-000046 · joyce_frm4.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,254 F1 · price: Gift of 16,000 shares to immediate family members. Read SEC document |
| October 30, 2017 Filed Nov 3, 2017 14:31 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | ConversionRestricted Stock Units · Derivative | 39,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-17-002824 · joyce_frm4.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,564 Underlying: Common Stock · 39,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 30, 2017. F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 30, 2017. Read SEC document |
| October 30, 2017 Filed Nov 3, 2017 14:31 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 19,079 | $0.98 | $18,697.42 |
DisclosureSEC source: 0001683168-17-002824 · joyce_frm4.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 15:51 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | ConversionRestricted Stock Units · Derivative | 39,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-17-002650 · joyce_frm4.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,189 Underlying: Common Stock · 39,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 11, 2017. F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted units will vest each quarter beginning 1/1/17. Represents conversion of restricted stock units with common stock issued as of October 11, 2017. Read SEC document |
| October 11, 2017 Filed Oct 13, 2017 15:51 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 19,079 | $1.14 | $21,750.06 |
DisclosureSEC source: 0001683168-17-002650 · joyce_frm4.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. Number of shares issued is net of number withheld for grantee taxes. No securities were bought or sold, rather restricted stock units were exercised. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units; options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
| May 01, 2017 Filed May 2, 2017 16:02 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Disposition to issuerRestricted Stock Units · Derivative | 19,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-17-001075 · joyce_f4-050117.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,814 Underlying: Common Stock · 19,079 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17 Represents conversion of restricted stock units with common stock issued on May 1, 2017 (with an effective date of April 28, 2017). F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17 Represents conversion of restricted stock units with common stock issued on May 1, 2017 (with an effective date of April 28, 2017). Read SEC document |
| May 01, 2017 Filed May 2, 2017 16:02 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 19,079 | $2.23 | $42,546.17 |
DisclosureSEC source: 0001683168-17-001075 · joyce_f4-050117.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 19:54 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Disposition to issuerRestricted Stock Units · Derivative | 98,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-17-000256 · joyce_f4.xml · derivative · entry 2 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,893 Underlying: Common Stock · 98,107 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. F3 · derivative.exercise_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17Represents conversion of restricted stock units with common stock issued on February 7, 2017. F3 · derivative.expiration_date: 158,500 of the restricted stock units vested on the grant date, and 39,625 restricted stock units will vest each quarter beginning 1/1/17Represents conversion of restricted stock units with common stock issued on February 7, 2017. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 19:54 UTC | AETHLON MEDICAL INC AEMD · Entity 8580 | Exercise / conversionCommon Stock | 98,107 | $4.28 | $419,897.96 |
DisclosureSEC source: 0001683168-17-000256 · joyce_f4.xml · nonDerivative · entry 1 Joyce James A · CIK 0001318931 · Director · Chairman, CEO, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock, originally issued on August 9, 2016. F1 · balance_after: In addition to the currently outstanding shares of common stock owned by Mr. Joyce and reported here, Mr. Joyce also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 50,000 shares of common stock at $18.00 per share; options to purchase 90,000 shares of common stock at $12.50 per share; options to purchase 20,000 shares of common stock at $5.00 per share; options to purchase 20,000 shares of common stock at $9.50 per share and vested restricted stock units as set forth in Table II above. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.